ES2132163T3 - Composicion farmaceutica de liberacion controlada en forma de suspension liquida. - Google Patents
Composicion farmaceutica de liberacion controlada en forma de suspension liquida.Info
- Publication number
- ES2132163T3 ES2132163T3 ES93119587T ES93119587T ES2132163T3 ES 2132163 T3 ES2132163 T3 ES 2132163T3 ES 93119587 T ES93119587 T ES 93119587T ES 93119587 T ES93119587 T ES 93119587T ES 2132163 T3 ES2132163 T3 ES 2132163T3
- Authority
- ES
- Spain
- Prior art keywords
- controlled release
- naproxen
- liquid suspension
- administration
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000013270 controlled release Methods 0.000 title abstract 3
- 239000006194 liquid suspension Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 abstract 4
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 abstract 3
- 229960002009 naproxen Drugs 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE PRESENTA UNA FORMULACION FARMACEUTICA CON UN REVESTIMIENTO ENTERICO, DE LIBERACION CONTROLADA, EN SUSPENSION LIQUIDA PARA LA ADMINISTRACION DE NAPROXENO QUE CONTIENE (A) MICROGRANULOS DE NAPROXENO Y UN EXCIPIENTE; (B) CUATRO REVESTIMIENTOS SUCESIVOS DE MATERIALES HIDROFILICOS E HIDROFOBICOS POLIMERICOS, EN DONDE LOS REVESTIMIENTOS QUE PRIMERO SE APLICAN IMPARTEN UNAS PROPIEDADES DE LIBERACION CONTROLADA A DICHO NAPROXENO SEGUN UN PERFIL DE LIBERACION PREDETERMINADO; Y (C) UN VEHICULO DE ADMINISTRACION DE LIQUIDOS. ESTA COMPOSICION PERMITE LA ADMINISTRACION ORAL DE NAPROXENO A MODO DE UNA SOLA DOSIS DIARIA Y EL AJUSTE DE LA DOSIFICACION SEGUN LOS REQUISITOS DEL PACIENTE, LO QUE AYUDA A LA TOMA ORAL Y MINIMIZA LOS EFECTOS SECUNDARIOS TIPICOS DEL FARMACO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI922826A IT1256651B (it) | 1992-12-11 | 1992-12-11 | Composizione farmaceutica a rilascio controllato in sospensione liquida |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2132163T3 true ES2132163T3 (es) | 1999-08-16 |
Family
ID=11364448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93119587T Expired - Lifetime ES2132163T3 (es) | 1992-12-11 | 1993-12-06 | Composicion farmaceutica de liberacion controlada en forma de suspension liquida. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0601508B1 (es) |
JP (1) | JPH06279274A (es) |
AT (1) | ATE178209T1 (es) |
DE (1) | DE69324214T2 (es) |
ES (1) | ES2132163T3 (es) |
IT (1) | IT1256651B (es) |
SG (1) | SG54207A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1270216B (it) * | 1994-06-14 | 1997-04-29 | Recordati Chem Pharm | Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari |
GB9611328D0 (en) * | 1996-05-31 | 1996-08-07 | Zeneca Ltd | Pharmaceutical compositions |
DE19648576C2 (de) * | 1996-11-23 | 1999-08-12 | Lohmann Therapie Syst Lts | Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt |
US6004582A (en) * | 1997-05-30 | 1999-12-21 | Laboratorios Phoenix U.S.A, Inc. | Multi-layered osmotic device |
SE9903879D0 (sv) * | 1999-10-28 | 1999-10-28 | Ethical Pharmaceuticals Sweden | Multipor food protection |
FR2822834B1 (fr) | 2001-04-02 | 2005-02-25 | Flamel Tech Sa | Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2837100B1 (fr) | 2002-03-18 | 2004-07-23 | Flamel Tech Sa | Comprimes a bases de microcapsules a liberation modifiee |
ATE407674T1 (de) | 2002-04-09 | 2008-09-15 | Flamel Tech Sa | Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin |
FR2843881B1 (fr) * | 2002-09-02 | 2006-06-02 | Flamel Tech Sa | Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s) |
ATE419840T1 (de) | 2002-04-09 | 2009-01-15 | Flamel Tech Sa | Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen |
FR2843117B1 (fr) | 2002-07-30 | 2004-10-15 | Flamel Tech Sa | Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques |
FR2860516B1 (fr) | 2003-10-03 | 2006-01-13 | Flamel Tech Sa | Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques |
FR2862536B1 (fr) | 2003-11-21 | 2007-11-23 | Flamel Tech Sa | Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques |
WO2006017159A1 (en) * | 2004-07-09 | 2006-02-16 | Drugtech Corporation | Controlled phase composition technology as an improved process for protection of drugs |
US9962336B2 (en) | 2014-05-01 | 2018-05-08 | Sun Pharmaceutical Industries Limited | Extended release suspension compositions |
US20180104197A9 (en) | 2014-05-01 | 2018-04-19 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of metformin |
US10258583B2 (en) * | 2014-05-01 | 2019-04-16 | Sun Pharmaceutical Industries Limited | Extended release liquid compositions of guanfacine |
RU2016147009A (ru) | 2014-05-01 | 2018-06-04 | Сан Фармасьютикал Индастриз Лимитед | Композиции с пролонгированным высвобождением в виде суспензии |
EP3174515A4 (en) | 2014-07-30 | 2018-03-21 | Sun Pharmaceutical Industries Limited | Dual-chamber pack |
US10238803B2 (en) | 2016-05-02 | 2019-03-26 | Sun Pharmaceutical Industries Limited | Drug delivery device for pharmaceutical compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571333A (en) * | 1983-06-14 | 1986-02-18 | Syntex (U.S.A.) Inc. | Controlled release naproxen and naproxen sodium tablets |
EP0178299A4 (en) * | 1984-03-21 | 1987-04-28 | Key Pharma | DOSAGE FORM FOR NAPROXYN FOR PERMANENT ADMINISTRATION IN THE MOUTH. |
IE58110B1 (en) * | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
IT1231410B (it) * | 1987-09-22 | 1991-12-04 | Cooperativa Farmaceutica | Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
IT1226940B (it) * | 1988-09-16 | 1991-02-22 | Recordati Chem Pharm | Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide |
IE902829A1 (en) * | 1989-08-14 | 1991-02-27 | Eurand America | Microencapsulated taste-masked water-insoluble nsaid drug¹materials |
IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
-
1992
- 1992-12-11 IT ITMI922826A patent/IT1256651B/it active IP Right Grant
-
1993
- 1993-12-06 AT AT93119587T patent/ATE178209T1/de not_active IP Right Cessation
- 1993-12-06 DE DE69324214T patent/DE69324214T2/de not_active Expired - Fee Related
- 1993-12-06 ES ES93119587T patent/ES2132163T3/es not_active Expired - Lifetime
- 1993-12-06 SG SG1996004299A patent/SG54207A1/en unknown
- 1993-12-06 EP EP93119587A patent/EP0601508B1/en not_active Expired - Lifetime
- 1993-12-10 JP JP5310680A patent/JPH06279274A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SG54207A1 (en) | 1998-11-16 |
ITMI922826A1 (it) | 1994-06-11 |
ATE178209T1 (de) | 1999-04-15 |
ITMI922826A0 (it) | 1992-12-11 |
DE69324214D1 (de) | 1999-05-06 |
IT1256651B (it) | 1995-12-12 |
DE69324214T2 (de) | 1999-08-19 |
EP0601508B1 (en) | 1999-03-31 |
EP0601508A3 (en) | 1995-10-25 |
JPH06279274A (ja) | 1994-10-04 |
EP0601508A2 (en) | 1994-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132163T3 (es) | Composicion farmaceutica de liberacion controlada en forma de suspension liquida. | |
BR9809328A (pt) | Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa | |
ITMI942484A0 (it) | Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione | |
DE69229490D1 (de) | Melatonin enthaltende Arzneimittel | |
WO2000018447A3 (en) | Multiplex drug delivery system suitable for oral administration | |
AU2553992A (en) | Bone-growth-stimulating composition | |
WO1994027557A3 (en) | Pharmaceutical thermal infusion process | |
CA2145513A1 (en) | Pharmaceutical Tablet Capable of Liberating One or More Drugs at Different Release Rates | |
DE69638364D1 (de) | Formulierungen mit kontrollierter abgabe (albuterol) | |
AU1225795A (en) | Combinations of an organic nitrate and a salicylate | |
DE3681755D1 (de) | Wirkstofftraeger und diesen enthaltende arzneimittel. | |
DE69214755D1 (de) | Thiazolidin-2,4-Dionderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
ES2180251T3 (es) | Comprimido revestido con polimero, que contiene amoxicilina y clavulanato. | |
NO884947L (no) | Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse. | |
ES2023649B3 (es) | Formas de dosificacion y administracion para medicamentos, reactivos o similares asi como procedimiento para su obtencion. | |
ITMI921022A1 (it) | Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale. | |
DE69228674D1 (de) | Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung | |
AR013967A1 (es) | UNA FORMULACION MEDICAMENTOSA PARA LA ADMINISTRACION ORAL DE PELLET DE DIFUSION CONTROLADA QUE TIENE LIBERACION CONTROLADA DE UN COMPUESTO ACTIVO QUE ES SELECCIONADO DEL ACIDO 1-CICLOPROPIL-7- [(S,S)-2,8-DIAZABICICLO [4.3.0] NON-8-IL ]-6-FLuOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-QUINOLON CARBOXILICO O SALE | |
SE8701479L (sv) | Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav | |
DE60142305D1 (de) | Pharmazeutische zubereitung enthaltend n-ä2-(1,6,7,8-tetrahydro-2h-indenoä5,4 büfuran-8-yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung | |
AU625402B2 (en) | Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances | |
ES2124889T3 (es) | Composicion distribuidora de farmacos para agentes bloqueadores alfa-adreno receptores. | |
ITMI942483A0 (it) | Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione | |
EE9600202A (et) | Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm | |
DE69914472D1 (de) | Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 601508 Country of ref document: ES |